Skip to contentHelp us improve by providing feedback or contacting help@jisc.ac.uk
  • Browse
  • Publish
Sign in with ORCID

disease nafld

Research Topic

Language: English

Sign in for more actions

This is a research topic created to provide authors with a place to attach new problem publications.

Research topics above this in the hierarchy

  • chronic inflammation

Research problems linked to this topic

  • Nonalcoholic fatty liver disease (NAFLD) is the hepatic component of the metabolic syndrome.
  • Obesity and diabetes mellitus are known to lead to the development of metabolic syndrome and non-alcoholic fatty liver disease (NAFLD).
  • Non-alcoholic fatty liver disease (NAFLD) has a rising prevalence worldwide.
  • Restenosis is a major limitation of coronary angioplasty, requiring further intervention in the majority of cases.
  • Nonalcoholic fatty liver disease (NAFLD) is a common liver disorder that can be divided into benign steatosis or nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH).

Octopus

Contact us: help@jisc.ac.uk

Browse

Publish

About

FAQs

Get involved

Terms

Privacy

Accessibility

Cookie Policy

In partnership with

Jisc Logo

With support from

UKRI

A collaboration with

Jisc Logo